Anhalt GJ. American Academy of CME, Meet the Authors: Insights That Impact Your Patients With Pemphigus, 13th Congress of the European Academy of Dermatology, November 18th, 2004, Firenze, Italy.
Bose SK, Lacour JP, Bodokh I, Ortonne JP. Malignant lymphoma and dermatitis herpetiformis, Dermatology 1994; 188: 177-181.Go to original source...Go to PubMed...
Crichlow SM, Mortimer NJ, Harman KE. A successful therapeutic trial of rituximab in the treatment of a patient with recalcitrant, high-titre epidermolysis bullosa acquisita, Br. J. Dermatol. 2007; 156(1): 194-196.Go to original source...Go to PubMed...
Dieterich W, Laag E, Bruckner-Tuderman L, Reunala T, Karpati S, Zágoni T, Riecken EO, Schuppan D. Antibodies to tissue transglutaminase as serological markers in patients with dermatitis herpetiformis, J. Invest. Dermatol. 1999; 113: 133-136.Go to original source...Go to PubMed...
Fry L. Dermatitis herpetiformis: problems, progress and prospects, Eur. J. Dermatol. 2002; 12(6): 523-531.
Hashimoto T, Amagai M, Garrod DR, Nishikawa T. Immunofluorescence and immunoblot studies on the reactivity of pemphigus vulgaris and pemphigus foliaceus sera with desmoglein 3 and desmoglein 1, Epithelial Cell Biol. 1995; 4(2): 63-69.
Hertl M. Epidermale Struktur- und Adhäsionsmoleküle, Fortschritte der praktischen Dermatologie und Venerologie 2004. Springer Verlag, 2005: 279-285.Go to original source...
Chan L. Bullous pemphigoid, e-medicine, http://emedicine.medscape.com/article/1062391-diagnosis.
Chan L, Woodley D. Epidermolysis bullosa acquisita, e-medicine, http://emedicine.medscape.com/article/1063083-overview.
Chen M, Chan LS, Cai X, O' Toole EA, Sample JC, Woodley DT. Development of an ELISA for rapid detection of anti-type VII collagen autoantibodies in epidermolysis bullosa acquisita., J Invest Dermatol. 1997; 108(1): 68-72.Go to original source...Go to PubMed...
Ioannides D, Chrysomallis F, Bystryn JC. Ineffectiveness of cyclosporine as an adjuvant to corticosteroids in the treatment of pemphigus, Arch. Dermatol. 2000; 136; 868-872.Go to original source...Go to PubMed...
Joly P, French Study Group on Autoimmune bullous disorders. Treatment of severe types of pemphigus using Rituximab (mabthera): preliminary results. 13th Congress of the European Academy of Dermatology, November 19th, 2004, Firenze, Italy.
Labib RS, Anhalt GJ, Patel HP, Mutasim DF, Diaz LA. Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting., J. Immunol. 1986; 136(4): 1231-1235.Go to original source...Go to PubMed...
Lewis HM, Reunala T, Garioch JJ, et al. Protective effect of gluten-free diet against development of lymphoma in dermatitis herpetiformis, B. r J. Dermatol. 1996; 133: 363-367.Go to original source...
Marinkovich MP. Electronic Textbook of Dermatology: Blistering diseases, http://www.telemedicine.org./blisters.html.
Matis WL, Anhalt GJ, Diaz LA, Rivitti EA, Martins CR, Berger RS. Calcium Enhances the Sensitivity of Immunofluorescence for Pemphigus Antibodies. J. Inves. Dermatol. 1987; 89: 302-304.Go to original source...Go to PubMed...
Zeina B, Mansoor S. Pemphigus vulgaris, e-medicine, http://emedicine.medscape.com/article/1064187-diagnosis.
Zillikens D. Epidermale Struktur- und Adhäsionsmoleküle, Fortschritte der praktischen Dermatologie und Venerologie 2004. Springer Verlag, 2005: 8-14.Go to original source...
Madam, Sir, please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert). Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.
I declare:
that I have met the above instruction
I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited